<DOC>
	<DOCNO>NCT00764361</DOCNO>
	<brief_summary>This study double-blind , one center , two-arm study two ( 2 ) week Run-In , evaluate efficacy once-daily administration NanoDOX™ Hydrogel topically apply diabetic ulcer concert professionally administer Standard Care ( SOC ) procedures described Standard Operating Procedure ( ) Department Veterans Administration Hospitals . During run-in period patient infected wound receive oral antibiotic include topical portion study infection show wound fluid analysis resolve . Following two ( 2 ) week Run-In patient receive SOC treatment diabetic ulcer , patient would either investigational material placebo hydrogel apply part wound care . Each patient would receive 1.5 gm packet either test article placebo hydrogel once-daily home treatment accompany dress change .</brief_summary>
	<brief_title>Safety Study Topical Doxycycline Gel Adult Diabetic Lower Extremity Ulcers</brief_title>
	<detailed_description>Study NanoDOX v placebo diabetic ulcer low leg/foot .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Have document history type I type II diabetes mellitus define American Diabetes Association Women childbearing potential must negative urine pregnancy test screen baseline , : • Agree use doublebarrier method contraception participation study ; condom ( spermicide ) hormonal contraceptive OR condom ( spermicide ) intrauterine device OR intrauterine device hormonal contraceptive OR Abstains sexual intercourse participation study OR Is samesex partner participate bisexual activity risk become pregnant Have ulcer low extremity ( distal line connect medial lateral malleoli ) present least 3 week 1.2 cm2 4.0 cm2 initial screening Be able apply study drug ulcer , caregiver Adequate blood flow target ulcer extremity measure transcutaneous oxygen tension ( TcpO2 ) &gt; 30mmHg Target ulcer Grade I accord Wagner Grading Scale Quantitative bacterial count &lt; 1.0 x 1.0E5 per gram tissue noninfected ulcer Quantitative bacterial count ≥ 1.0 x 1.0E5 per gram tissue infect ulcer Be pregnant lactate woman female childbearing potential practicing acceptable form birth control . Allergy tetracycline , minocycline , demeclocycline , know tetracycline derivative Have three chronic ulcer present baseline Have undergo treatment system corticosteroid immunosuppressive therapy past 2 month Have connective tissue disease Currently go kidney dialysis renal failure Have undergo treatment doxycycline , Procuren® , Regranex® within last 30 day Have participate another clinical research trial within last 30 day Have know history osteomyelitis affect area target ulcer present Have concomitant condition , opinion investigator , would make subject unsuitable study . Subject ulcer result cause diabetes ( electrical burn , arterial insufficiency , chemical radiation insult )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Diabetic</keyword>
	<keyword>Ulcer</keyword>
	<keyword>Wound</keyword>
</DOC>